Kronos Bio Inc (KRON)
1.02
-0.01
(-0.97%)
USD |
NASDAQ |
May 03, 16:00
1.01
-0.01
(-0.98%)
After-Hours: 20:00
Kronos Bio Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
Date | Value |
---|---|
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2023
--
Maximum
Mar 2023
--
Average
--
Median
Mar 2023
Debt to Equity Ratio Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 213.28M |
Total Liabilities (Quarterly) | 54.20M |
Shareholders Equity (Quarterly) | 159.08M |
Current Ratio | 7.239 |